In FiercePharma’s top headlines of 2018, you’ll see not only which stories hit a nerve with the most readers—including a few eyebrow-raisers—but several themes that either dominated the news all year
Merck & Co. boasted some major success in the sales department this year, but the company’s commercial organization will still get a makeover for 2019.
The CEO job at Spanish drugmaker Almirall lured Sanofi EVP Peter Guenter away from his role leading the company's diabetes and cardiovascular business.